Hey guys, if you missed it, Doximity ($DOCS) agreed to a $31M settlement with investors over claims that the company masked declining sales.
Quick recap: On April 1, 2024, Jehosaphat Research released a report raising concerns about Doximity’s healthcare advertising business. After the report came out, $DOCS fell, wiping out more than $135M in shareholder value over two days.
Now, the good news is that the company agreed to settle $31M with them, and even though the deadline has passed recently, they’re accepting late claims.
If you held $DOCS between 2021 and 2023, you can still check the details and see if you may be eligible[ here](https://11th.com/cases/doximity-investor-suit).
